TP53 and neoplasm: These mutant p53 proteins (mutp53) not only lose their tumor-suppressive functions but also display dominant-negative and neomorphic properties (often referred to as gain-of-function, GOF), switching p53 from a tumor suppressor to a protein with oncogenic activity [3–6].